肺动脉自体移植物包裹技术在成人二叶主动脉瓣Ross手术中的长期结局
该单术者回顾性研究比较了129例成人二叶主动脉瓣患者行Ross手术时使用或不使用肺动脉自体移植物包裹技术的长期结局。中位随访10.3年,包裹组自体移植物再干预需求显著低于未包裹组(亚风险比0.28,95%CI 0.08-0.91,P=.035),且自体瓣膜失败率更低(5.2% vs 35.2%)。结论认为包裹技术可稳定主动脉根部、减少再手术,使Ross手术在该人群中获得优异长期结果。
要点
- 包裹组10年自体移植物再干预累积发生率为4.0%,未包裹组为26.8%。
- 包裹组自体瓣膜失败3例(5.2%),未包裹组25例(35.2%)。
- 两组1、5、10年生存率无显著差异(P=.15)。
核心结论
- 在成人二叶主动脉瓣患者中,使用肺动脉自体移植物包裹技术的Ross手术可稳定主动脉根部、防止扩张并减少再手术需求。
- 包裹技术使Ross手术在该人群中可行且长期结局优异。
研究设计与样本
- 1992年至2019年单术者回顾性队列研究,纳入129例年龄≥18岁的二叶主动脉瓣行Ross手术的成人。
- 分为未包裹组(n=71)和包裹组(n=58),中位随访10.3年(四分位距3.0-16.8年)。
- 采用竞争风险分析评估自体移植物再干预需求。
主要发现
- 两组术前和术中特征以及30天并发症或死亡率无差异。
- 未包裹组1、5、10年生存率分别为97.2%、97.2%、95.6%,包裹组均为100%(P=.15)。
- 自体瓣膜失败在未包裹组发生25例(35.2%),包裹组3例(5.2%)。
- 竞争风险分析显示包裹组再干预需求更低(亚风险比0.28,95%CI 0.08-0.91,P=.035)。
- 以死亡为竞争结局,未包裹组1、5、10年再干预累积发生率分别为10.2%、14.9%、26.8%,包裹组均为4.0%。
关键数值与推荐
- 包裹组再干预亚风险比0.28(95%CI 0.08-0.91,P=.035)。
- 未包裹组10年再干预累积发生率26.8%,包裹组4.0%。
临床怎么用
- 对成人二叶主动脉瓣行Ross手术时,可考虑采用肺动脉自体移植物包裹技术以降低远期再干预风险。
- 该技术可能通过稳定主动脉根部、防止扩张来改善长期耐久性。
局限性
- 单术者回顾性队列研究,可能存在选择偏倚。
- 样本量有限(129例),随访时间中位10.3年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare outcomes with wrapped (pulmonary autograft inclusion) versus unwrapped techniques in adults with bicuspid aortic valves undergoing the Ross procedure. METHODS: Between 1992 and 2019, 129 adults with bicuspid aortic valves (aged ≥18 years) underwent the Ross procedure by a single surgeon. Patients were divided into those without autograft inclusion (unwrapped, n = 71) and those with autograft inclusion (wrapped, n = 58). Median follow-up was 10.3 years (interquartile range, 3.0-16.8 years). Need for autograft reintervention was analyzed using competing risks. RESULTS: Pre- and intraoperative characteristics as well as 30-day morbidity or mortality did not differ between cohorts. Survival at 1, 5, and 10 years, respectively, was 97.2%, 97.2%, and 95.6% in the unwrapped cohort and 100%, 100%, and 100% in the wrapped cohort (P = .15). Autograft valve failure occurred in 25 (35.2%) of the unwrapped and 3 (5.2%) of the wrapped patients. Competing risks analysis demonstrated the wrapped cohort to have a lower need for autograft reintervention (subhazard ratio, 0.28, 95% confidence interval, 0.08-0.91; P = .035). The cumulative incidence of autograft reintervention (death as a competing outcome) at 1, 5, and 10 years, respectively, was 10.2%, 14.9%, and 26.8% in the unwrapped cohort and 4.0%, 4.0%, and 4.0% in the wrapped cohort. CONCLUSIONS: In adults with bicuspid aortic valves, the Ross procedure with pulmonary autograft inclusion stabilizes the aortic root preventing dilatation and reduces the need for reoperation. The autograft inclusion technique allows the Ross procedure to be performed in this population with excellent long-term outcomes.
引用
- Starnes VA, Elsayed RS, Cohen RG, et al. Long-term outcomes with the pulmonary autograft inclusion technique in adults with bicuspid aortic valves undergoing the Ross procedure. J Thorac Cardiovasc Surg. 2021. PMID: 33685733. doi:10.1016/j.jtcvs.2021.01.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。